Magnetic Resonance Imaging (MRI) Correlation to Standard of Care Imaging and Pathology Correlation in Breast Carcinoma
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Magnetic Resonance Imaging (MRI) is a well known imaging tool for the investigation and diagnosis of breast cancer, used in addition to breast mammograms and ultrasound. Recent publications suggest that MRI may be the best test to use in women who have very dense breasts, have a family history of breast cancer and have had breast cancer and were treated with breast saving measures. MRI has been shown to be a better tool to show multiple breast cancer spots than mammography or ultrasound. The radiologists and the radiology students will have the opportunity to review the MRI scans along with the breast ultrasound and mammography films and the pathology reports from the breast cancer surgery completed at the CCI. This may enable them to learn how the various subtypes of breast cancer look on MRI. The goal is: 1) to gain good breast MRI expertise, giving the Radiology residents a complete diagnostic program. 2) to develop good MRI breast experience, enabling the Cross Cancer Institute to be the centre of excellence for Breast MRI for northern Alberta.
| Condition | Intervention | Phase |
|---|---|---|
|
-Breast Neoplasms |
Procedure: MRI |
Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label |
| Official Title: | Magnetic Resonance Imaging (MRI) Correlation to Standard of Care Imaging and Pathology Correlation in Breast Carcinoma |
- -assess how MRI of the breast correlates to standard of care which includes ultrasound, mammography, biopsy and surgery [ Time Frame: 2 years ] [ Designated as safety issue: No ]
- -assess how the MRO correlates to the breast cancer pathology collected at the CCI [ Time Frame: 2 years ] [ Designated as safety issue: No ]
| Enrollment: | 72 |
| Study Start Date: | March 2006 |
| Study Completion Date: | January 2010 |
| Primary Completion Date: | January 2010 (Final data collection date for primary outcome measure) |
-
Procedure: MRI
Show Detailed Description
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- females 18 years or older
- females referred to Dr. Kelly Dabbs for breast cancer surgery with pathology positive for breast carcinoma, any subtype
Exclusion Criteria:
- pacemakers
- aneurysm clips
- cochlear implants
- epicardial pacemaker wires
- neural stimulators, etc.
- significant claustrophobia
- significant obesity that would not enable the patient to fit in the scanner
- pregnancy or breast feeding
Contacts and Locations
More Information
No publications provided
| Responsible Party: | Alberta Health Services |
| ClinicalTrials.gov Identifier: | NCT00291304 History of Changes |
| Other Study ID Numbers: | BR-1-0082 |
| Study First Received: | February 13, 2006 |
| Last Updated: | December 8, 2011 |
| Health Authority: | Canada: Health Canada |
Keywords provided by Alberta Health Services:
|
Magnetic Resonance Imaging Pathology |
Additional relevant MeSH terms:
|
Breast Neoplasms Neoplasms Carcinoma Neoplasms by Site |
Breast Diseases Skin Diseases Neoplasms, Glandular and Epithelial Neoplasms by Histologic Type |
ClinicalTrials.gov processed this record on May 19, 2013